BCRX BioCryst Pharmaceuticals, Inc.

NASDAQ
$7.30

BioCryst Pharmaceuticals, Inc. (BCRX) Earnings News

Earnings press releases, previews and reviews for BioCryst Pharmaceuticals, Inc. (BCRX), newest first. Our most recent is review: BioCryst Beats on ORLADEYO Strength, but a One-Time Pharmacy Inventory Build Explains Why Product Guidance Stayed Put.